Chemical Compound
BUPRENORPHINE HYDROCHLORIDE
CAS Registry Number
53152-21-9
Primary Record
BUPRENORPHINE HYDROCHLORIDE
- In stock
- 6,462 g
- Purity
- 99.8 %
- CAS
- 53152-21-9
Compound Identifiers & Properties
- CAS
- 53152-21-9
- PubChem CID
- 3033050
- SMILES
- C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)(C(C)(C)C)O.Cl
- Canonical SMILES
- CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5.Cl
Names & Synonyms
- BUPRENORPHINE HYDROCHLORIDE
- Buprenex
- Finibron
- Belbuca
- Subutex
- Buprenorphine Hcl
- buprenorphine
- Temgesic
- Buprex
- Probuphine
- Vetergesic
- Buprederm
- Anorfin
- Lepetan
- Nopan
- Espranor
- Prefibin
- Simbadol
- Transtec
- Butrans
- Norspan
- Natzon
- Gabup
- Buprenorphine.HCl
- Ethiqa XR
- BEMA-buprenorphine
- Buprenorphine Depot
- Buprenex (TN)
- BEMA LA
- Buprenorphine Sublingual
- RefChem:56706
- RX 6029-M HCl
- 56W8MW3EN1
- UNII-56W8MW3EN1
- BEMA long acting analgesic
- BUPRENORPHINE HCL SL
- AC1MHV55
- Hydrochloride, Buprenorphine
- NIH8805
- Buprenorphine hydrochloride ciii
- RX6029-M HCL
- C29H41NO4.ClH
- Epitope ID:2270795
- UM 952
- Buprenorphine (hydrochloride)
- DTXSID2048905
- RX-6029-M HCL
- 53152-21-9
- NIH 8805
- NIH-8805
- CHEBI:652822
- Buprenorphine Sublingual C-III
- MR 56
- TSN-09
- DEA No. 9064
- DTXCID9028831
- SCHEMBL17220698
- EINECS 258-396-8
- ETI-311
- UAIXRPCCYXNJMQ-RZIPZOSSSA-N
- C29-H41-N-O4.Cl-H
- Buprenorphine hydrochloride solution
- CL 112,302
- SCH-028444
- BCP16140
- FTB-8127
- HY-B0701
- CL-112302
- RX 6029-M
- UM-952
- Buprenorphine Hydrochloride Sublingual
- CID3033050
- CL 112302
- CS-2940
- IX-1003
- IX-1004
- IX-1005
- Buprenorphine hydrochloride (JP17/USP)
- BUPRENORPHINE HYDROCHLORIDE [MI]
- Buprenorphine hydrochloride [USAN:JAN]
- Buprenorphine hydrochloride [USAN:USP:JAN]
- M-6029
- BUPRENORPHINE HYDROCHLORIDE [JAN]
- Buprenorphine hydrochloride CRS - * psy
- BUPRENORPHINE HYDROCHLORIDE [USAN]
- Buprenorphine hydrochloride[ORANGE BOOK]
- CL112302
- BUPRENORPHINE HYDROCHLORIDE [MART.]
- BUPRENORPHINE HYDROCHLORIDE [VANDF]
- BUPRENORPHINE HYDROCHLORIDE [USP-RS]
- BUPRENORPHINE HYDROCHLORIDE [WHO-DD]
- BUNAVAIL COMPONENT BUPRENORPHINE HYDROCHLORIDE
- D00836
- V-1003
- V-1004
- V-1005
- BUPRENORPHINE HYDROCHLORIDE [EP IMPURITY]
- BUPRENORPHINE HYDROCHLORIDE [EP MONOGRAPH]
- BUPRENORPHINE HYDROCHLORIDE [USP IMPURITY]
- BUPRENORPHINE HYDROCHLORIDE [USP MONOGRAPH]
- SUBOXONE COMPONENT BUPRENORPHINE HYDROCHLORIDE
- Buprenorphine.HCl, 1mg/ml in Methanol (as free base)
- Q27105186
- (5alpha,7alpha(S))-alpha-tert-Butyl-17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinan-7-methanol hydrochloride
- 21-Cyclopropyl-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine hydrochloride
- 52485-79-7
- Buprenorphine hydrochloride solution, analytical standard, for drug analysis
- Buprenorphine hydrochloride, British Pharmacopoeia (BP) Reference Standard
- Buprenorphine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
- Buprenorphine hydrochloride, United States Pharmacopeia (USP) Reference Standard
- (18R)-17-(Cyclopropylmethyl)-18-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-6-methoxy-5alpha,6beta,14beta-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol--hydrogen chloride (1/1)
- (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol;hydrochloride
- (2S)-2-((5R,6R,7R,14S)-17-(Cyclopropylmethyl)-4,5-epoxy-3-hydroxy-6-methoxy-6,14-ethanomorphinan-7-yl)-3,3-dimethylbutan-2-ol monohydrochloride
- [5|A,7|A(S)]-17-(Cyclopropylmethyl)-|A-(1,1-dimethylethyl)4,5-epoxy-18,19-dihydo-3-hydroxy-6-methoxy-|A-methyl-6,14-ethenomorphinan-7-methanol hydrochloride
- [5alpha,7alpha(S)]-alpha-tert-butyl-17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinan-7-methanol hydrochloride
- 21-cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine hydrochloride
- 258-396-8
- 6,14-Etenomorfinan-7-metanol, 17-(ciclopropilmetil)-alfa-(1,1-dimetiletil)-4,5-epoxi-18,19-dihidro-3-hidroxi-6-metoxi-alfa metil-,clorhidrato (1:1)
- 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-.alpha.-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-.alpha.-methyl-, hydrochloride, (.alpha.S,5.alpha.,7.alpha.)-
- 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-.alpha.-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-.alpha.-methyl-, hydrochloride, [5.alpha.,7.alpha.(S)]-
- 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, hydrochloride (1:1), (alphaS,5alpha,7alpha)-
- 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, hydrochloride, (5alpha,7alpha(S))-
- 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, hydrochloride, [5alpha,7alpha(S)]-
- Buprenorphine hydrochloride; (2S)-2-[17-(Cyclopropylmethyl)-4,5a-epoxy-3-hydroxy-6-methoxy-6a,14-ethano-14a-morphinan-7a-yl]-3,3-dimethylbutan-2-ol hydrochloride; 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-a-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-a-methyl-, hydrochloride (1:1), (aS,5a,7a)-; 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-a-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-a-methyl-, hydrochloride, (aS,5a,7a)- (9CI); 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-a-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-a-methyl-, hydrochloride, [5a,7a(S)]-; Buprederm; Buprenex; Buprex; CL 112302; Lepetan; M 6029; MR 56; NIH 8805; UM 952; Vetergesic